A fire broke out at a pharmaceutical factory in Ankara, the capital city of Türkiye.

US regulators have announced plans to begin monitoring microplastics and pharmaceutical residues in drinking water, marking a first step towards assessing potential health risks and shaping future regulation.

US President Donald J. Trump has announced sweeping new tariffs on patented pharmaceutical products and their ingredients, invoking national security powers under Section 232 of the Trade Expansion Act of 1962.

The government has finalized the legal text of the U.K.-U.S. pharmaceutical deal, securing a commitment to boost the amount spent by Britain’s National Health Service on new medicines in exchange for zero tariffs.

Over the past several years a major shift has been taking place in the global manufacturing landscape. Increasing numbers of multinational corporations are moving part of their production to India.

Azerbaijan's President Ilham Aliyev attended the opening of a pharmaceutical production facility owned by Scandens Pharmaceutical Industries Ltd. in the village of Hokmali in Absheron District on Saturday.

The U.K.’s Trade Secretary, Peter Kyle, remarked that pharmaceutical companies are proving to be “hard negotiators” amid intense discussions related to President Donald Trump’s deadline to impose 100 percent tariffs on U.S. pharmaceutical imports.

Shares of major European pharmaceutical firms declined on Friday after U.S. President Donald Trump sent letters to 17 global drugmakers demanding they align U.S. prices with those offered in other countries. The move follows a sweeping executive order signed earlier this year aimed at curbing high drug costs in the United States.